Wednesday, August 5, 2026

HomeBusiness NewsClarity Pharmaceuticals reports clinical progress in June 2026 quarter

Clarity Pharmaceuticals reports clinical progress in June 2026 quarter

- Advertisement -


The Clarity Pharmaceuticals Ltd (ASX: CU6) share price is in focus today after the company reported a strong cash position of $178.3 million at 30 June 2026, and achieved key clinical and operational milestones as it advances its pipeline of cancer diagnostics and therapies towards…



Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed